June 17, 2016 Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days
Rentschler Biotechnologie GmbH announces that the 4th Laupheim Biotech Days took place June 13th to 14th, 2016 in Laupheim, Germany. This biannual event organized by Rentschler was held this year under the topic "Fusion Proteins – delivering novel therapeutic options". 170 participants from industry and academia experienced two exciting days at a high scientific level and in a pleasant atmosphere and infrastructure.
Like monoclonal antibodies, fusion proteins are among the major biopharmaceutical drugs or drug candidates applied in oncology, immunology and hematology. The group of fusion proteins includes both the well-established Fc fusion proteins such as Enbrel® and numerous innovative fusion protein platforms. In 12 presentations and during many discussions, the participants received a comprehensive overview of the current development status. Various fusion protein platforms were presented and a profound view into the cell culture-based manufacturing processes was given.
The keynote lecture was held by Hansjörg Hauser, German Helmholtz Centre for Infectious Diseases and the current chairman of the European Society for Animal Cell Technology. His presentation "Genetic engineering in cell culture technology" gave a great overview about the understanding of the cellular proliferation control, the impact of a targeted integration of heterologous DNA into the mammalian cell genome through to the generation of reliable and efficient production cell lines.
Students also participated at the event and in addition, they had the opportunity to get to know the company Rentschler and to inform about the career opportunities.
The 4th Laupheim Biotech Days were supported by a number of sponsors. Most of them presented their products and services at a booth during the whole event.
The sponsor names and the abstract book can be found at www.rentschler.de/aktuelles/4th-laupheim-biotech-days/.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication